We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$659M
AUM Growth
+$62.8M
Cap. Flow
+$10.2M
Cap. Flow %
1.55%
Top 10 Hldgs %
32.09%
Holding
2,763
New
252
Increased
1,197
Reduced
774
Closed
132

Sector Composition

Rank Sector Weight
1 Technology 13.29%
2 Financials 7.42%
3 Industrials 6.4%
4 Consumer Discretionary 5.47%
5 Healthcare 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADI icon
301
Analog Devices
ADI
$184B
$319K 0.05%
1,340
+276
+26% +$57.5K
UNH icon
302
UnitedHealth
UNH
$378B
$317K 0.05%
1,015
-1,034
-50% -$395K
INGR icon
303
Ingredion
INGR
$6.43B
$315K 0.05%
2,325
+572
+33% +$77.2K
TEL icon
304
TE Connectivity
TEL
$63.3B
$314K 0.05%
1,861
+841
+82% +$128K
EQNR icon
305
Equinor
EQNR
$91.3B
$312K 0.05%
12,400
+1,804
+17% +$43.6K
ZM icon
306
Zoom
ZM
$29.3B
$311K 0.05%
3,990
+312
+8% +$24.1K
AMED
307
DELISTED
Amedisys
AMED
$310K 0.05%
3,149
+371
+13% +$35.1K
EA icon
308
Electronic Arts
EA
$52.9B
$309K 0.05%
1,937
+65
+3% +$9.61K
CRWD icon
309
CrowdStrike
CRWD
$217B
$309K 0.05%
2,428
-264
-10% -$28.6K
DFUS
310
Dimensional US Equity ETF
DFUS
$21.6B
$309K 0.05%
4,604
-1,011
-18% -$62.6K
ALLE icon
311
Allegion
ALLE
$14.3B
$308K 0.05%
2,140
+115
+6% +$15.7K
NVCR icon
312
NovoCure
NVCR
$1.87B
$307K 0.05%
17,259
+3,560
+26% +$62K
TMO icon
313
Thermo Fisher Scientific
TMO
$213B
$307K 0.05%
757
-252
-25% -$105K
WSM icon
314
Williams-Sonoma
WSM
$29.3B
$306K 0.05%
1,874
-1,044
-36% -$164K
FNDE icon
315
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.79B
$305K 0.05%
9,234
-714
-7% -$22.2K
XYL icon
316
Xylem
XYL
$28.4B
$303K 0.05%
2,342
+1
+0% +$121
AZO icon
317
AutoZone
AZO
$49.8B
$301K 0.05%
81
-13
-14% -$47.9K
GTES icon
318
Gates Industrial Corporation Ltd.
GTES
$7.5B
$300K 0.05%
13,039
+3,186
+32% +$64.2K
VRTX icon
319
Vertex Pharmaceuticals
VRTX
$123B
$300K 0.05%
674
+47
+7% +$21.7K
DCI icon
320
Donaldson
DCI
$11.3B
$299K 0.05%
4,312
+2,099
+95% +$141K
TSN icon
321
Tyson Foods
TSN
$20.6B
$298K 0.05%
5,335
-2,070
-28% -$119K
AER icon
322
AerCap
AER
$24.5B
$297K 0.05%
2,540
+110
+5% +$11.9K
MT icon
323
ArcelorMittal
MT
$56.7B
$297K 0.05%
9,405
+1,810
+24% +$53.5K
PANW icon
324
Palo Alto Networks
PANW
$298B
$296K 0.05%
1,448
+93
+7% +$17.3K
DOCU
325
DocuSign
DOCU
$10.9B
$295K 0.04%
3,789
-817
-18% -$66.1K

Similar funds

Versant Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Versant Capital Management held 2,763 positions worth $659M, up 11% from $596M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Versant Capital Management's Q2 2025 filing shows 252 new, 1,197 increased, 774 reduced and 132 closed positions. Its largest new stake was iShares High Yield Muni Active ETF: 18,741 shares worth $911K. The largest sale was Vanguard Emerging Markets Government Bond ETF, an estimated $3.47M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Versant Capital Management's largest Q2 2025 buy was iShares High Yield Muni Active ETF: 18,741 shares worth $911K.
  • Versant Capital Management added most to Dimensional US Marketwide Value ETF in Q2 2025, an estimated $1.99M increase.
  • Versant Capital Management's biggest Q2 2025 reduction was Vanguard Emerging Markets Government Bond ETF, cutting an estimated $3.47M.
  • Versant Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $273K.
  • Versant Capital Management's ten largest holdings make up 32% of its $659M portfolio in Q2 2025.
  • Versant Capital Management opened 252 new positions and closed 132 in Q2 2025.
  • Versant Capital Management's portfolio value rose 11% quarter-over-quarter to $659M.

Based on Versant Capital Management's 13F filing for Q2 2025, filed 7 Jul 2025.